Agency: European Commission | Branch: FP7 | Program: CP-TP | Phase: KBBE.2012.3.1-01 | Award Amount: 11.66M | Year: 2012
The goal of WATBIO is to use the power of next generation sequencing to develop an accelerated route for producing new germplasm with enhanced drought tolerance whilst maintaining biomass productivity and quality in water scarce, marginal environments unsuitable for food crops. This will be achieved for three non-food crops (Populus, Miscanthus and Arundo), suitable for growth on water scarce, marginal lands, through a 5-year translational research project. Populus and Miscanthus germplasm with increased drought tolerance will be produced within WATBIO whilst for Arundo its genetic diversity will be assessed and breeding tools developed. Twenty-two multidisciplinary partners (14 academics, and 7 SMEs) spanning the whole value chain for crop production will collectively achieve this innovation by 1) identifying key molecular, cellular and physiological traits for the maintenance of biomass production, lignocellulosic quality and water use efficiency in water-scarce environments; 2) linking these traits through modelling to underlying key genes, proteins and metabolite networks; 3) utilising a wide range of germplasm for screening in phenotyping platforms and field measurements at multiple sites to test importance of genotype x environment interactions in determining traits; 4) using sequence based gene expression data, identify 40 genes related to drought tolerance for testing proof of concept using GM approach; and 5) using sequence-based data for genome wide association and genetical genomic approaches, link physiology to traits of high heritability and to underlying genes. WATBIO will transfer knowledge of commercial significance using its industrial partners and stakeholders enabling the deployment of biotechnology to boost European competitiveness, without the necessity of GM. Through workshops, seminars and exchanges, WATBIO will train the next generation of multi-disciplinary professionals in the area of biomass crop production on marginal lands.
Trebbi D.,Geneticlab Srl |
Papazoglou E.G.,National and Kapodistrian University of Athens |
Saadaoui E.,National Water Research Institute |
Vischi M.,University of Udine |
And 6 more authors.
Industrial Crops and Products | Year: 2015
The aim of this work was to estimate the genetic diversity among 273 Jatropha curcas L. accessions and to develop a new SNP-based multi-allelic marker assay (Intra-Locus SNP Haplotype, or LSH) to enhance the genetic discriminatory power of the SNP marker system. The accessions were collected in 15 countries of 3 continents (Africa, Asia and America) and analyzed with SSR, EST-SSR and SNP markers. Cluster analysis revealed the presence of two main genetic groups with an extreme high genetic uniformity and homozygosity of accessions grown in all countries of Africa, Asia, South America, and in some states of Mexico. Differently, an increased genetic variability and heterozygosity was observed in other states of Mexico and Guatemala. The newly developed LSH assay successfully identifies multiple alleles at the same locus and increased the average polymorphic information content of the SNP system. These results confirm the general idea recognizing the Central America region as the center of origin of the species and the genetic homogeneity of the world-wide cultivated accessions, and propose a new powerful SNP-based multi-allelic marker assay for enhancing genetic diversity analysis and selection methods in breeding programs. © 2015.
Ambrosi D.G.,University of Padua |
Galla G.,University of Padua |
Purelli M.,Geneticlab Srl |
Barbi T.,Geneticlab Srl |
And 4 more authors.
Diversity | Year: 2010
Jatropha curcas L. (2n = 2x = 22) is becoming a popular non-food oleaginous crop in several developed countries due to its proposed value in the biopharmaceutical industry. Despite the potentials of its oil-rich seeds as a renewable source of biodiesel and an interest in large-scale cultivation, relatively little is known with respect to plant reproduction strategies and population dynamics. Here, genomic DNA markers and FCSS analyses were performed to gain insights into ploidy variation and heterozygosity levels of multiple accessions, and genomic relationships among commercial varieties of Jatropha grown in different geographical areas. The determination of ploidy and the differentiation of either pseudogamous or autonomous apomixis from sexuality were based on the seed DNA contents of embryo and endosperm. The presence of only a high 2C embryo peak and a smaller 3C endosperm peak (ratio 2:3) is consistent with an obligate sexual reproductive system. Because of the lack of either 4C or 5C endosperm DNA estimates, the occurrence of gametophytic apomixis seems unlikely in this species but adventitious embryony cannot be ruled out. The investigation of genetic variation within and between cultivated populations was carried out using dominant RAPD and Inter-SSR markers, and codominant SSR markers. Nei's genetic diversity, corresponding to the expected heterozygosity, was equal to H e = 0.3491 and the fixation index as low as F st = 0.2042. The main finding is that seeds commercialized worldwide include a few closely related genotypes, which are not representative of the original Mexican gene pool, revealing high degrees of homozygosity for single varieties and very low genetic diversity between varieties. © 2010 by the authors; licensee MDPI, Basel, Switzerland.
Agency: European Commission | Branch: H2020 | Program: SME-2 | Phase: PHC-12-2014 | Award Amount: 1.70M | Year: 2015
The main scope of LEONID project is the development and validation of the clinical performance of a new diagnostic Nanostring-based device against existing standards (FISH and IHC) for the detection of in vitro biomarkers with predictive power of response to tyrosin kinase inhibitors used for lung cancer treatment. The device will be the first CE-IVD kit that detects all ALK, ROS1 and RET rearrangements with known and unknown partners in one multiplex assay and that, at the same time, identify the main variants of EML4-ALK. The clinical validation will be extended to the associated software for secondary analysis of data that will guarantee the results standardization, avoiding any personal interpretation. The new diagnostic device-software combination, that passed the technical feasibility analysis and is ready for experimental verification, will be the easiest, cheapest, fastest and standardized solution for ALK, ROS1 and RET fusions detection without losing sensitivity, specificity, robustness and reproducibility. The end users will be all molecular pathology laboratories supporting hospitals where lung cancer patients are treated, that (are going to) perform the analysis of fusion genes and want to reduce hands-on-time, error rate, and costs, saving specialized technical expertise and increasing the throughput of biomarkers and samples. At least 85 European medium-high throughput labs running 450 lung samples per year can be considered as potential customers. For Diatech Pharmacogenetics, the new device will be complementary to the existing products for pharmacogenetics analysis in oncology and will boost the companys approach of potential European distributors. GeneticLab can offer the test to low throughput labs and can speed up the entrance into the oncology business. BiMind can extend the panel of features of its proprietary oncology EHR dedicated to the analysis of laboratory tests results and can provide its new software through Diatech PGx or directly.
Geneticlab S.r.l. | Date: 2015-12-23
The present invention refers to a chemical mixture for the stabilization and conservation of organic material, preferably of human nature, such as for example cells and nucleic acids. In particular, the invention is relative to a mixture that makes it possible to stabilize and conserve at ambient temperature for a few days cells and/or nucleic acids isolated from a sample of human biological fluids such as, for example, whole blood. The mixture is characterized by the presence of siloxanic polymers.